These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 25911294)

  • 1. Central Precocious Puberty: Update on Diagnosis and Treatment.
    Chen M; Eugster EA
    Paediatr Drugs; 2015 Aug; 17(4):273-81. PubMed ID: 25911294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined treatment with gonadotropin-releasing hormone analog and growth hormone in central precocious puberty.
    Pasquino AM; Municchi G; Pucarelli I; Segni M; Mancini MA; Troiani S
    J Clin Endocrinol Metab; 1996 Mar; 81(3):948-51. PubMed ID: 8772556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Critical Appraisal of the Effect of Gonadotropin-Releasing Hormon Analog Treatment on Adult Height of Girls with Central Precocious Puberty.
    Bereket A
    J Clin Res Pediatr Endocrinol; 2017 Dec; 9(Suppl 2):33-48. PubMed ID: 29280737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined use of growth hormone and gonadotropin-releasing hormone analogues: the national cooperative growth study experience.
    Kohn B; Julius JR; Blethen SL
    Pediatrics; 1999 Oct; 104(4 Pt 2):1014-8. PubMed ID: 10506254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term effects and significant Adverse Drug Reactions (ADRs) associated with the use of Gonadotropin-Releasing Hormone analogs (GnRHa) for central precocious puberty: a brief review of literature.
    De Sanctis V; Soliman AT; Di Maio S; Soliman N; Elsedfy H
    Acta Biomed; 2019 Sep; 90(3):345-359. PubMed ID: 31580327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of a potent, long acting agonist of gonadotropin-releasing hormone in the treatment of precocious puberty.
    Boepple PA; Mansfield MJ; Wierman ME; Rudlin CR; Bode HH; Crigler JF; Crawford JD; Crowley WF
    Endocr Rev; 1986 Feb; 7(1):24-33. PubMed ID: 2937629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes of Patients with Central Precocious Puberty Due to Loss-of-Function Mutations in the MKRN3 Gene after Treatment with Gonadotropin-Releasing Hormone Analog.
    Ramos CO; Macedo DB; Canton APM; Cunha-Silva M; Antonini SRR; Stecchini MF; Seraphim CE; Rodrigues T; Mendonca BB; Latronico AC; Brito VN
    Neuroendocrinology; 2020; 110(7-8):705-713. PubMed ID: 31671431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adult height in girls with central precocious puberty treated with gonadotropin-releasing hormone analogues and growth hormone.
    Pasquino AM; Pucarelli I; Segni M; Matrunola M; Cerroni F
    J Clin Endocrinol Metab; 1999 Feb; 84(2):449-52. PubMed ID: 10022399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toward More Targeted and Cost-Effective Gonadotropin-Releasing Hormone Analog Treatment in Girls with Central Precocious Puberty.
    Kaplowitz PB; Backeljauw PF; Allen DB
    Horm Res Paediatr; 2018; 90(1):1-7. PubMed ID: 30048994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of combined treatment with growth hormone and gonadotropin releasing hormone analogue in children with poor prognosis of adult height.
    Toumba M; Bacopoulou I; Savva SC; Skordis N
    Indian Pediatr; 2007 Jul; 44(7):497-502. PubMed ID: 17684302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Update on central precocious puberty: from etiologies to outcomes.
    Cantas-Orsdemir S; Eugster EA
    Expert Rev Endocrinol Metab; 2019 Mar; 14(2):123-130. PubMed ID: 30763521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adult height, body mass index and time of menarche of girls with idiopathic central precocious puberty after gonadotropin-releasing hormone analogue treatment.
    Poomthavorn P; Suphasit R; Mahachoklertwattana P
    Gynecol Endocrinol; 2011 Aug; 27(8):524-8. PubMed ID: 21501002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MANAGEMENT OF ENDOCRINE DISEASE: Long-term outcomes of the treatment of central precocious puberty.
    Guaraldi F; Beccuti G; Gori D; Ghizzoni L
    Eur J Endocrinol; 2016 Mar; 174(3):R79-87. PubMed ID: 26466612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-Term Outcomes of Patients with Central Precocious Puberty due to Hypothalamic Hamartoma after GnRHa Treatment: Anthropometric, Metabolic, and Reproductive Aspects.
    Ramos CO; Latronico AC; Cukier P; Macedo DB; Bessa DS; Cunha-Silva M; Arnhold IJ; Mendonca BB; Brito VN
    Neuroendocrinology; 2018; 106(3):203-210. PubMed ID: 28558376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of a Gonadotropin-releasing Hormone Analog to Treat Idiopathic Central Precocious Puberty Is Not Associated with Changes in Bone Structure in Postmenarchal Adolescents.
    Iannetta R; Melo AS; Iannetta O; Marchini JS; Paula FJ; Martinelli CE; Rosa e Silva AC; Ferriani RA; Martins WP; Reis RM
    J Pediatr Adolesc Gynecol; 2015 Oct; 28(5):304-8. PubMed ID: 26081481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment and outcomes of precocious puberty: an update.
    Fuqua JS
    J Clin Endocrinol Metab; 2013 Jun; 98(6):2198-207. PubMed ID: 23515450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased final adult height by gonadotropin-releasing hormone agonist in girls with idiopathic central precocious puberty.
    Lee HS; Yoon JS; Park KJ; Hwang JS
    PLoS One; 2018; 13(8):e0201906. PubMed ID: 30133462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Central precocious puberty: current treatment options.
    Antoniazzi F; Zamboni G
    Paediatr Drugs; 2004; 6(4):211-31. PubMed ID: 15339200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gonadotropin releasing hormone analogue therapy in girls with idiopathic precocious puberty/early-fast puberty: dynamics in adiposity indices, eating habits and quality of life.
    Loochi SA; Demol S; Nagelberg N; Lebenthal Y; Phillip M; Yackobovitch-Gavan M
    J Pediatr Endocrinol Metab; 2021 Mar; 34(3):373-383. PubMed ID: 33609438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gonadotropin-Releasing Hormone (GnRHa) Therapy for Central Precocious Puberty (CPP): Review of Nuances in Assessment of Height, Hormonal Suppression, Psychosocial Issues, and Weight Gain, with Patient Examples.
    Klein KO; Lee PA
    Pediatr Endocrinol Rev; 2018 Apr; 15(4):298-312. PubMed ID: 29806750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.